Abstracts
11 June 2009
Vol. 3 No. 1 (2009)
https://doi.org/10.4081/hmr.v3i1.545
0
0
0
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Innovative treatments: bortezomib

Authors

PL Zinzani
support@pagepress.org
The incidence of non-Hodgkin's lymphoma (NHL) has markedly increased in the US and Western Europe in recent years and presents a considerable clinical challenge. Despite many advances in the treatment of NHL, the challenge to develop treatments far the disease remains. For example, there are few effective treatment options for patients with mantle celI lymphoma (MCL) and, while there are a number of therapies that can induce remission in patients with follicular lymphoma (FL), the disease remains incurable. Recently, preclinical and clinical studies have shown the potential for proteasome inhibition in the treatment of NHL.

Altmetrics

Downloads

Citations

Crossref
0
Scopus
0
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



Innovative treatments: bortezomib. (2009). Hematology Meeting Reports, 3(1). https://doi.org/10.4081/hmr.v3i1.545